{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:58:03Z","timestamp":1778788683350,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.urolonc.2010.05.001","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T06:48:06Z","timestamp":1284706086000},"page":"306-313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["High matrix metalloproteinase-to-E-cadherin ratio measured by bicolor fluorescent in situ hybridization is associated with lymphangiogenesis and lymph node metastasis in prostate cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Yi","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyomu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitomo","family":"Chihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kuniyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2010.05.001_bib1","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/S0022-5347(01)62251-1","article-title":"The combination of preoperative prostate specific antigen and postoperative pathologic findings to predict outcome in clinically localized prostate cancer","volume":"160","author":"D'Amico","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2010.05.001_bib2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jnci\/90.10.766","article-title":"A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer","volume":"90","author":"Kattan","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2010.05.001_bib3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.1997.03540420041027","article-title":"The use of prostate-specific antigen, clinical stage, and Gleason score to predict pathologic stage in men with localized prostate cancer: A multi-institutional update","volume":"277","author":"Partin","year":"1997","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.urolonc.2010.05.001_bib4","first-page":"2295","article-title":"Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor\/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers","volume":"6","author":"Kuniyasu","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2010.05.001_bib5","first-page":"2185","article-title":"The relative mRNA expression levels of matrix metalloproteinase to E-cadherin in prostate biopsy specimens distinguishe organ-confined from advanced prostate cancer at radical prostatectomy","volume":"9","author":"Kuniyasu","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2010.05.001_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng0503-23a","article-title":"Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population","volume":"34","author":"Fidler","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2010.05.001_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: The \u2018seed and soil\u2019 hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2010.05.001_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1196\/annals.1413.021","article-title":"Lymphatic vessel activation in cancer","volume":"1131","author":"Das","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.urolonc.2010.05.001_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.suronc.2006.10.002","article-title":"The metastatic cascade in prostate cancer","volume":"15","author":"Arya","year":"2006","journal-title":"Surg Oncol"},{"key":"10.1016\/j.urolonc.2010.05.001_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jso.21225","article-title":"Lymph node assessment and lymphadenectomy in prostate cancer","volume":"99","author":"Ordon","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.urolonc.2010.05.001_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/cncr.22034","article-title":"Current status of lymph node-positive prostate cancer: Incidence and predictors of outcome","volume":"107","author":"Swanson","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2010.05.001_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1196\/annals.1413.020","article-title":"Molecular control of lymphatic metastasis","volume":"1131","author":"Achen","year":"2008","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.urolonc.2010.05.001_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1160\/TH03-04-0200","article-title":"Lymphangiogenic growth factors, receptors, and therapies","volume":"90","author":"Lohela","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.urolonc.2010.05.001_bib14","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1158\/1078-0432.CCR-06-1800","article-title":"Pathways targeting tumor lymphangiogenesis","volume":"12","author":"Wissmann","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2010.05.001_bib15","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/j.1349-7006.2008.00894.x","article-title":"High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma","volume":"99","author":"Sasahira","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.urolonc.2010.05.001_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000094494","article-title":"Determinants for prediction of malignant potential by metalloproteinase: E-cadherin ratio in prostate core needle biopsy","volume":"73","author":"Ohmori","year":"2006","journal-title":"Pathobiology"},{"key":"10.1016\/j.urolonc.2010.05.001_bib17","series-title":"AJCC Cancer Staging Manual","author":"Greene","year":"2003"},{"key":"10.1016\/j.urolonc.2010.05.001_bib18","first-page":"937","article-title":"A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas","volume":"53","author":"Radinsky","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2010.05.001_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1177\/41.4.8095509","article-title":"A rapid colorimetric in situ mRNA hybridization technique using hyperbiotinylated oligonucleotide probes for analysis of mdr-1 in mouse colon carcinoma cells","volume":"41","author":"Bucana","year":"1993","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.urolonc.2010.05.001_bib20","first-page":"25","article-title":"Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma","volume":"5","author":"Kuniyasu","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2010.05.001_bib21","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/path.1031","article-title":"Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer","volume":"196","author":"Kuniyasu","year":"2002","journal-title":"J Pathol"},{"key":"10.1016\/j.urolonc.2010.05.001_bib22","first-page":"1541","article-title":"Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma","volume":"149","author":"Kitadai","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urolonc.2010.05.001_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1432-0436.1996.6020119.x","article-title":"Intratumoral heterogeneity and inverse correlation between expression of E-cadherin and collagenase type IV in human gastric carcinomas","volume":"60","author":"Anzai","year":"1996","journal-title":"Differentiation"},{"key":"10.1016\/j.urolonc.2010.05.001_bib24","first-page":"790","article-title":"Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma","volume":"6","author":"Herbst","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2010.05.001_bib25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1245\/ASO.2004.01.013","article-title":"The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer","volume":"11","author":"Tamura","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2010.05.001_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/147323000803600411","article-title":"Relationship between protein expression of VEGF-C, MMP-2, and lymph node metastasis in papillary thyroid cancer","volume":"36","author":"Tian","year":"2008","journal-title":"J Int Med Res"},{"key":"10.1016\/j.urolonc.2010.05.001_bib27","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1038\/sj.onc.1202850","article-title":"RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases","volume":"18","author":"Aguirre-Ghiso","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2010.05.001_bib28","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/sj.onc.1209971","article-title":"RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation","volume":"26","author":"Rinaldo","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2010.05.001_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00441-007-0477-4","article-title":"Gene regulation by homeobox transcription factor Prox1 in murine hepatoblasts","volume":"330","author":"Papoutsi","year":"2007","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.urolonc.2010.05.001_bib30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tcb.2005.06.004","article-title":"Molecular lymphangiogenesis: New players","volume":"15","author":"Tammela","year":"2005","journal-title":"Trends Cell Biol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143910001250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143910001250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:57:39Z","timestamp":1761040659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143910001250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1078143910001250"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2010.05.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High matrix metalloproteinase-to-E-cadherin ratio measured by bicolor fluorescent in situ hybridization is associated with lymphangiogenesis and lymph node metastasis in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2010.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}